This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The following content was originally published by EVERSANA last June; read on to learn more, and then get EVERSANA’s complete whitepaper about the benefits of creating reusable infrastructure and resources when it comes to product launches.
A sustainability process for product development and system design was established and Berlinger’s SmartSystem , the first climate neutral product available for cold chain monitoring of pharmaceuticalproducts , was born. Download the whitepaper to learn more. [1] 1] [link]. [2] 2] [link].
QbD principles are woven into regulatory guidance documents, primarily guidances Q8 to Q11 of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). This presents an obvious financial benefit in the form of cost savings and helps guarantee the safety and reliability of the final product.
Furthermore, having local knowledge at terminals regarding available freight space ensures efficiency and allows aircraft to carry as many products as possible. To learn more about how Tanner is adapting to changes in the clinical trial supply chain and embracing technological innovations, download this whitepaper.
This process is used to manufacture pharmaceuticalproducts with low molecular weights in large batches within a short timescale. Chemical synthesis is the artificial execution of chemical reactions. The chemical synthesis process enables various chemical modifications to be made in order to enhance the activity of the drug produced.
Freeze drying has found many applications in the production of sensitive and high-value food, drink and pharmaceuticalproducts. Proper monitoring and control methods help manufacturers carry out the freeze drying, or lyophilisation, process correctly and consistently.
A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceuticalproducts. The evolution of CCIT. Free Webinar.
The potential scale of new infections and the questionable ability of parts of China’s hospital system to deal with the current wave of infections may lead to supply chain disruptions for the manufacture and export of active pharmaceutical ingredients (APIs) due to an adverse impact on workforce availability and delays at export hubs.
To learn more about how to choose an appropriate antimicrobial agent for a new pharmaceuticalproduct and whether Benzalkonium Chloride could be a good choice for your next formulation, download the short webinar below. Is recombinant insulin a factor to consider for viral production? Free Whitepaper.
The potential scale of new infections and the questionable ability of parts of China’s hospital system to deal with the current wave of infections may lead to supply chain disruptions for the manufacture and export of active pharmaceutical ingredients (APIs) due to an adverse impact on workforce availability and delays at export hubs.
Palmadottir predicts that unit-level tracking is next on the horizon, with pharmaceutical supply chain teams knowing where every single unit is at any given moment. Palmadottir also says that the lesson of Covid-19 vaccines is that it is possible to ramp up and down the production of pharmaceuticalproducts on a massive scale.
Creating a more resistant supply chain For available products, the guidelines include considerations on the conversion of batch manufacturing practices to continuous manufacturing. Many pharmaceuticalproducts are made through a step-by-step process known as batch manufacturing.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content